Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$201K Buy
+555
New +$190K 0.03% 182
2015
Q2
Sell
-16,586
Closed -$2.65M 84
2015
Q1
$2.65M Sell
16,586
-315
-2% -$49.6K 2.16% 13
2014
Q4
$2.69M Buy
16,901
+8,845
+110% +$1.38M 2.27% 11
2014
Q3
$1.13M Sell
8,056
-20
-0.2% -$2.61K 1% 46
2014
Q2
$956K Sell
8,076
-50
-0.6% -$5.79K 0.83% 47
2014
Q1
$1M Sell
8,126
-174
-2% -$21.1K 0.85% 49
2013
Q4
$947K Buy
+8,300
New +$944K 0.87% 48

Other funds holding AMGN

Addison Capital's AMGN Position: Q2 2026 in Review

Addison Capital opened a new position in Amgen (AMGN) in Q2 2026: 555 shares worth $201K. The stake represents 0.03% of the portfolio and ranks #182 among its holdings. This is a return to the name: Addison Capital previously reported a position in AMGN as recently as Q1 2015.

Addison Capital first reported a position in AMGN in Q4 2013 and has held it in 7 quarters since. The position peaked at $2.69M in Q4 2014. 3,153 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Addison Capital held 555 shares of Amgen worth $201K as of Q2 2026.
  • Amgen was a new Addison Capital position in Q2 2026.
  • Amgen made up 0.03% of Addison Capital's portfolio in Q2 2026, its #182 holding.
  • Addison Capital first reported a position in Amgen in Q4 2013 and has held it in 7 quarters since.
  • Addison Capital's Amgen position peaked at $2.69M in Q4 2014.
  • 3,153 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Addison Capital's 13F filing for Q2 2026, filed 4 Aug 2026.